Literature DB >> 33150585

British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020.

S G Keohane1,2, J Botting3,4, P G Budny5,6, O M Dolan7, K Fife8,9, C A Harwood10, R Mallipeddi1,11, J R Marsden12, R J Motley13, C Newlands14,15, C Proby16, A Rembielak8,17,18, D N Slater19, J A Smithson20,21, P Buckley22, P Fairbrother23, M Hashme24, M F Mohd Mustapa24, L S Exton24.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33150585     DOI： 10.1111/bjd.19621

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  8 in total

Review 1.  Dermoscopy as an adjunct to surgical excision of nonmelanoma Skin lesions: a systematic review and Meta-analysis.

Authors:  Anna R Hurley; Joshua P Totty; Richard M Pinder
Journal:  J Clin Aesthet Dermatol       Date:  2022-09

Review 2.  A structured review of quality of life in advanced and high-risk cutaneous squamous cell carcinoma shows the need for more studies and better measures.

Authors:  R Starkings; V Shilling; V Jenkins; L Fallowfield
Journal:  Skin Health Dis       Date:  2021-05-07

3.  The impact of COVID-19 on nonmelanoma skin cancer: the experience of an Irish dermatology department. Comment on: 'Influence of Covid-19 confinement on the size of malignant skin tumours surgically removed at a Spanish hospital'.

Authors:  Anna Wolinska; Gregg Murray; Stephanie Bowe; Sinead Collins; Clióna Feighery; Aizuri Murad
Journal:  Clin Exp Dermatol       Date:  2022-05-22       Impact factor: 4.481

Review 4.  Evidence from Clinical Studies Related to Dermatologic Surgeries for Skin Cancer.

Authors:  Shoichiro Ishizuki; Yoshiyuki Nakamura
Journal:  Cancers (Basel)       Date:  2022-08-08       Impact factor: 6.575

Review 5.  Recent Advances in the Diagnosis and Management of High-Risk Cutaneous Squamous Cell Carcinoma.

Authors:  Clio Dessinioti; Alexander J Stratigos
Journal:  Cancers (Basel)       Date:  2022-07-21       Impact factor: 6.575

6.  A network pharmacology-based exploration of the active compounds and potential drug targets of Si-Jun-Zi decoction in the treatment of cutaneous squamous cell carcinoma.

Authors:  Si Qin; Lan-Yue Zhang; Hao-Bin Zhang; Si-Man Shi; Xin Zhou; Zhen-Yu Lu; Yi-Xue Duan; Wen-Bin Huang; Ju Wen
Journal:  Transl Cancer Res       Date:  2022-08       Impact factor: 0.496

7.  Risk factors for distant metastasis in cutaneous squamous cell carcinoma.

Authors:  Nicholas Stefanovic; Conor J Fitzmaurice; Patrick Ormond; Alan D Irvine; Rupert B Barry
Journal:  Br J Dermatol       Date:  2022-05-27       Impact factor: 11.113

8.  Growth and Viability of Cutaneous Squamous Cell Carcinoma Cell Lines Display Different Sensitivities to Isoform-Specific Phosphoinositide 3-Kinase Inhibitors.

Authors:  Viviana Mannella; Kira Boehm; Suheyla Celik; Tasnim Ali; Amnah N Mirza; Mariam El Hasnaouy; Andreas Kaffa; Yanshuang Lyu; Donya Kafaei Golahmadi; Irene M Leigh; Daniele Bergamaschi; Catherine A Harwood; Tania Maffucci
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.